Further, in another study, compound 1 was able to cause SrcK inhibition in human cells derived from lung adenocarcinoma (A549), which led to downregulation of focal adhesion kinase (FAK), underlining the fact that interaction of CSs with NKA in cancer cells leads to different outcomes than in non-transformed cells [116]. This evidence concerns the gene PTK2 and cancer.